You are here: Industry Insights > Clinical Trials

News List

ABS plans to undertake human clinical trials in New Brunswick, Canada biospectrumasia
October 09, 2017
Upon successful completion of the human clinical trials, ABS intends to establish a manufacturing facility in New Brunswick, to serve ABS’s customers globally.
BiondVax Receives Additional Grant Funding americanpharmaceuticalreview
August 21, 2017
BiondVax Pharmaceuticals announced the Israel Innovation Authority (IIA) agreed to fund up to 40% of a NIS 2.7 million (approximately US$ 750,000) budget towards ongoing development of M-001, the company's Universal Flu Vaccine candidate.
What revolutionary changes the new draft for comment of CFDA on clinical trials will bring? en-cphi.cn
June 02, 2017
CFDA issued the Relevant Policies on Encouraging the Innovation of Drugs and Medical Devices and Reforming the Administration of Clinical Trials (Draft for Comment) at midnight of May 11 to solicit comments from the society.
ASIA: Preferred destination for clinical trials biospectrumasia
June 02, 2017
While the globalization of clinical research is driving growth in Asia, there are a few challenges relating to regulatory complexities, infrastructure and legal issues, and language and cultural hurdles.
Worldwide Clinical Trials Appoints Clinical Ops VP contractpharma
May 26, 2017
Nowatkoski brings extensive senior clinical operations
Athenex and Its Partner, Guangzhou Xiangxue Pharmaceutical, Announced Chinese FDA IND Approval to Be en-cphi.cn
May 25, 2017
Athenex, Inc., Buffalo, NY announced Guangzhou Xiangxue Pharmaceutical Co. Ltd., (Xiangxue) has received the Chinese FDA Investigational New Drug (IND) approval to begin clinical trials for...
CFDA consecutively issued new policies to lift controls over medical device and clinical trials en-cphi.cn
May 18, 2017
China Food and Drug Administration (CFDA) consecutively issued four reform policies (drafts for comment) on May 11 to solicit public opinions from the society.
FDA allows novel inhaled lung cancer treatment to commence clinical trials europeanpharmaceuticalreview
April 26, 2017
North Carolina based Biomarck Pharmaceuticals has received FDA allowance to begin human trials for their patented compound BIO-11006, for adults with lung cancer.
VWR Acquires MESM Ltd. americanpharmaceuticalreview
April 10, 2017
VWR a provider of product and service solutions to laboratory and production customers, has acquired MESM Ltd.
High doses of vitamin C to improve cancer treatment passes human safety trial worldpharmanews
April 01, 2017
Clinical trials found that it is safe to regularly infuse brain and lung cancer patients with 800 - 1000 times the daily recommended amount of vitamin C as a potential strategy to improve outcomes of standard cancer treatments.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 13 14 Next page